Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Science

No description
by

on 18 June 2015

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Science

LGC
science
families

Reference Materials (PT) and measurements
Molecular biology
Chromatography and mass spectrometry
Instrumentation, software and data handling
Protein and cell biology
Characterisation / investigation
Well characterised samples are essential to laboratories for demonstrating method performance and for quality control.
We are expert at preparing homogeneous stable materials, characterising content and certifying to meet market requirements.
DNA/RNA sequence, genotype and quantity are increasingly important to most sectors of industry.
Eg: to identify crime suspects, understand crop performance and thereby improve quality and yield, advance medical research and disease diagnosis, and prove the authenticity of foods.
The majority of (bio)chemical measurements require detecting and quantifying specific molecules in complex mixtures. Chromatography enables separation of mixed components and its combination with mass spectrometry (which provides molecular weight information and 'fingerprints') represents the gold standard in analysis.
Science equips us to innovate in providing solutions to customers, but with the related challenge of delivering these as packages, and of managing the large datasets that are often derived.
Protein therapy development is growing faster than small molecules
To understand disease often needs research at the cell level
Cells could replace the use of animals in areas of new product development
Customers often come to us to provide solutions to the issues they face. These can be as diverse as seeking expert opinion on evidence from a crime scene to providing advice on manufacturing problems or in product development.
Activities
Producers forum meeting (quarterly)
Capability presentations and webinars
Secondment (Dana Hedrick - Manchester to Teddington)
Technology road map
Around 1/3 of LGC's business relates to DNA/RNA methods and reagents. We have leading experts in research and applied markets and have a powerful IP and equipment portfolio to support customer needs.
Activities
Newsletter (monthly - Rhian Gwilliam)
Young scientists identified as communication vehicle
Technology road map
Activities
Joint conference with protein group planned on bio-characterisation/ biosimilars
Technology road map
Activities
Strong linkage with IT (digital and e-commerce development)
Current practice across the organisation (statistics, experimental design)
Activities
Meetings of the group post S&S conference in May
Biosimilars meeting / creativity workshops
Technology road map
Activities
Site visit programme in planning
Database of capability being established on i-know
Objectives
Establish families
Increase awareness
Health check (in relation to business)

Consistency, standardisation and coordination
External promotion (webinars, conferences, etc)
External relations (partnerships)
Mentoring of next generation of science leaders
R&D investment
New product / service development
Genomics
ParaDNA
Product line extension
Investments in catalogue extensions in Standards
Genomics
Business relationships
Key customers and partners in Genomics
Standards suppliers
Process efficiency
Toxicology
Automation
Contract R&D
NMI
ParaDNA, US DoD
Summary
Families getting established
Firm set of goals for 14/15
R&D in organisation now understood
Mechanisms for measuring return
Project, process and knowledge management needs attention.
Future
Other science family outcomes
Innovation and creativity
Developing our science families
We have invested heavily in state of the art instrumentation in chromatography and mass spectrometry and provide solutions to customers through our expert workforce, many of whom are renowned as leaders in their fields.
We have instrument and software design capability that has enabled the manufacture of equipment to meet market demand and expert statisticians and informatics knowledge to ensure that outputs are effectively interpreted.
We have advanced knowledge and instrumentation in measuring and characterising proteins in complex samples, and in characterising cells and carrying out cell-based assays.
Using the breadth of capability that we possess, which includes a rand of specialist equipment, our scientists are renowned for their problem solving and interpretation skills.
Full transcript